Gorilla and King Portfolio Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: megazoo who wrote (3441)	7/5/1999 4:22:00 PM
From: Percival 917	Read Replies (1) of 54805

To SXB, RE: VISX...... I am a Doctor of Optometry by profession and am quite familiar with Visx and Summit Tech. If you will check further you will find that a major part of their income is derived from a royalty that is paid by the Ophtalamologist doing the surgery, to them for each eye they operate on. Last time I checked it is on the order of $250 per eye which is why the surgeries are not going to come down in price anytime too soon. The FTC has a problem with this and as well as Doctors are looking at other Excimer Laser alternatives from other companies, so their monopoly may not last that much longer. You may well want to watch these events closely. I will send additional info in a few days but am out of town away from my desk right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next